Mabs Dominating Cancer Treatment Market Landscape
According to a new research report by RNCOS, Cancer Monoclonal Antibodies Market to 2015
, the global market for cancer monoclonal antibodies (mAbs) has advanced on the technological front as well as revenue patterns over the past few years. As the prevalence of cancer led to augment the mortality rate worldwide and resulted in burgeoning healthcare cost, the healthcare community started focusing on mAbs as an effective treatment option over chemotherapy. This, in turn, boosted the revenue patterns of private players engaged in the market. Backed by these factors and new drug launches, the global cancer mAb market is likely to advance at a CAGR of around 7% during the forecast period (2012-2015) to reach US$ 27 Billion.
According to the findings of the report, among all the key therapeutic segments in the cancer market worldwide, mAbs have emerged as a preferable treatment category in recent times. For instance, in 2011, antineoplastic mAbs are likely to have contributed around 36% share in the total cancer market. The share is large compared to the second largest treatment option, which is cytostatic. Further, it is expected that anti-neoplastic antibodies would increase their dominance in the global cancer drugs market.
The report Cancer Monoclonal Antibodies Market to 2015, investigates and analyzes all the key developments including the important drivers and key challenges confronted by the global cancer mAbs market. It also identifies the possible growth areas in terms of pipeline products and provides an in-depth analysis of the antineoplastic mAbs currently in development. Moreover, the report prudently evaluates the key market trends and illustrates their impact on the current and future performance of the market.
The report is an outcome of an extensive research and in-depth analysis of the global cancer mAb market that provides reliable statistics and seeks to use effective methods and techniques for future forecasting. While forecasting, a due consideration has been given to the ongoing research, key vertical sector demand, and developments, necessary to determine the future outlook of cancer antibody. Overall, the report depicts the most unbiased picture of the Global Cancer mAbs Market that will prove decisive for the investors and clients.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM375.htm
Some of our Related Reports are:
- Indian Healthcare - New Avenues for Growth (http://www.rncos.com/Report/IM151.htm)
- Insulin Delivery Systems Market Forecast to 2014 (http://www.rncos.com/Report/IM369.htm)
- Global Genetic Testing Market Analysis (http://www.rncos.com/Report/IM352.htm)
- US Diagnostic Market Outlook 2014 (http://www.rncos.com/Report/IM298.htm)
- Global In Vitro Diagnostic Market Analysis (http://www.rncos.com/Report/IM103.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
by: Shushmul Maheshwari
Four Treatments For Cellulite Issues Wonderful Ideas On How To Prevent Cancerous Cells Decorative Treatments For Floor Can Range From Parquet Flooring To Ceramic Tile Mosaics. The Common Treatments For Pimples Musings On Staying Young & Botox Treatments Ways To Fight Cancer Naturally Dont Panic Follow Correct Panic Attack Treatments The Dangers Of Canine Cancer Understanding Your Options For Prostate Cancer Treatment Crucial Tips For Earlier Detection Of Cancers Daily Tips For A Breast Cancer Diet The brain Tumors/cancer Evaluating Actos Bladder Cancer Cases